Porcine Xenograft Versus Second Intention Healing
Porcine Xenograft Versus Second Intention Healing: a Randomized, Evaluator-blinded Clinical Trial
Sponsor: Northwell Health
Terminated
Company discontinued production of the Porcine Xenograft
This NA trial investigates Wound Healing and Scar Quality Following Mohs Surgery and Excisional Dermatologic Surgery and is currently terminated or withdrawn. Northwell Health leads this study, which shows 11 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Apr 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Apr 2023 [monthly]
Terminated NA
Status: Completed → Terminated
-
Dec 2021 — Dec 2022 [monthly]
Completed NA
Status: Recruiting → Completed
▶ Show 6 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Recruiting NA
-
Apr 2020 — Jan 2021 [monthly]
Recruiting NA
-
Feb 2020 — Apr 2020 [monthly]
Recruiting NA
-
Aug 2019 — Feb 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2019 — Aug 2019 [monthly]
Not Yet Recruiting NA
-
May 2019 — Jun 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Northwell Health
For direct contact, visit the study record on ClinicalTrials.gov .